AMBBY
Price
$14.75
Change
-$0.29 (-1.93%)
Updated
Sep 4 closing price
Capitalization
3.97B
SAFLF
Price
$1.60
Change
+$0.10 (+6.67%)
Updated
Sep 2 closing price
Capitalization
710.16M
Interact to see
Advertisement

AMBBY vs SAFLF

Header iconAMBBY vs SAFLF Comparison
Open Charts AMBBY vs SAFLFBanner chart's image
Ambu A/S
Price$14.75
Change-$0.29 (-1.93%)
Volume$888
Capitalization3.97B
Safilo Group Spa
Price$1.60
Change+$0.10 (+6.67%)
Volume$100
Capitalization710.16M
AMBBY vs SAFLF Comparison Chart in %
Loading...
AMBBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMBBY vs. SAFLF commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMBBY is a Hold and SAFLF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (AMBBY: $14.75 vs. SAFLF: $1.60)
Brand notoriety: AMBBY and SAFLF are both not notable
AMBBY represents the Medical/Nursing Services, while SAFLF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMBBY: 119% vs. SAFLF: 0%
Market capitalization -- AMBBY: $3.97B vs. SAFLF: $710.16M
AMBBY [@Medical/Nursing Services] is valued at $3.97B. SAFLF’s [@Pharmaceuticals: Other] market capitalization is $710.16M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.15B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMBBY’s FA Score shows that 0 FA rating(s) are green whileSAFLF’s FA Score has 0 green FA rating(s).

  • AMBBY’s FA Score: 0 green, 5 red.
  • SAFLF’s FA Score: 0 green, 5 red.
According to our system of comparison, SAFLF is a better buy in the long-term than AMBBY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMBBY’s TA Score shows that 3 TA indicator(s) are bullish while SAFLF’s TA Score has 2 bullish TA indicator(s).

  • AMBBY’s TA Score: 3 bullish, 4 bearish.
  • SAFLF’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, both AMBBY and SAFLF are a bad buy in the short-term.

Price Growth

AMBBY (@Medical/Nursing Services) experienced а -6.94% price change this week, while SAFLF (@Pharmaceuticals: Other) price change was +6.67% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.15%. For the same industry, the average monthly price growth was +4.26%, and the average quarterly price growth was +24.88%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.57%. For the same industry, the average monthly price growth was +6.79%, and the average quarterly price growth was +18.37%.

Industries' Descriptions

@Medical/Nursing Services (-0.15% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-1.57% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMBBY($3.97B) has a higher market cap than SAFLF($710M). AMBBY has higher P/E ratio than SAFLF: AMBBY (70.62) vs SAFLF (12.28). SAFLF YTD gains are higher at: 63.215 vs. AMBBY (13.287). AMBBY has higher annual earnings (EBITDA): 834M vs. SAFLF (107M). AMBBY has more cash in the bank: 640M vs. SAFLF (72.6M). SAFLF has less debt than AMBBY: SAFLF (115M) vs AMBBY (554M). AMBBY has higher revenues than SAFLF: AMBBY (5.83B) vs SAFLF (999M).
AMBBYSAFLFAMBBY / SAFLF
Capitalization3.97B710M559%
EBITDA834M107M779%
Gain YTD13.28763.21521%
P/E Ratio70.6212.28575%
Revenue5.83B999M584%
Total Cash640M72.6M882%
Total Debt554M115M482%
FUNDAMENTALS RATINGS
AMBBY vs SAFLF: Fundamental Ratings
AMBBY
SAFLF
OUTLOOK RATING
1..100
3150
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
10072
SMR RATING
1..100
8170
PRICE GROWTH RATING
1..100
7736
P/E GROWTH RATING
1..100
59100
SEASONALITY SCORE
1..100
5032

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SAFLF's Valuation (64) in the null industry is somewhat better than the same rating for AMBBY (98). This means that SAFLF’s stock grew somewhat faster than AMBBY’s over the last 12 months.

SAFLF's Profit vs Risk Rating (72) in the null industry is in the same range as AMBBY (100). This means that SAFLF’s stock grew similarly to AMBBY’s over the last 12 months.

SAFLF's SMR Rating (70) in the null industry is in the same range as AMBBY (81). This means that SAFLF’s stock grew similarly to AMBBY’s over the last 12 months.

SAFLF's Price Growth Rating (36) in the null industry is somewhat better than the same rating for AMBBY (77). This means that SAFLF’s stock grew somewhat faster than AMBBY’s over the last 12 months.

AMBBY's P/E Growth Rating (59) in the null industry is somewhat better than the same rating for SAFLF (100). This means that AMBBY’s stock grew somewhat faster than SAFLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMBBYSAFLF
RSI
ODDS (%)
Bearish Trend 1 day ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
59%
Bearish Trend 1 day ago
57%
Momentum
ODDS (%)
Bearish Trend 1 day ago
74%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
59%
Bearish Trend 1 day ago
42%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
66%
Bullish Trend 1 day ago
27%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
72%
Bullish Trend 1 day ago
23%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
63%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
27%
View a ticker or compare two or three
Interact to see
Advertisement
AMBBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DESGX25.210.22
+0.88%
DWS ESG Core Equity Institutional
SWISX27.820.23
+0.83%
Schwab International Index
MGLJX16.340.12
+0.74%
MFS Global Real Estate R1
ADKSX34.320.24
+0.70%
Adirondack Small Cap
VLAAX41.620.17
+0.41%
Value Line Asset Allocation Investor

AMBBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMBBY has been loosely correlated with ICCM. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if AMBBY jumps, then ICCM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMBBY
1D Price
Change %
AMBBY100%
-1.93%
ICCM - AMBBY
35%
Loosely correlated
+0.95%
MDXH - AMBBY
34%
Loosely correlated
-1.67%
VTAK - AMBBY
25%
Poorly correlated
N/A
SAFLF - AMBBY
24%
Poorly correlated
N/A
CLPBY - AMBBY
23%
Poorly correlated
-0.92%
More

SAFLF and

Correlation & Price change

A.I.dvisor tells us that SAFLF and ICCM have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SAFLF and ICCM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAFLF
1D Price
Change %
SAFLF100%
N/A
ICCM - SAFLF
28%
Poorly correlated
+0.95%
MDXH - SAFLF
28%
Poorly correlated
-1.67%
XAIR - SAFLF
25%
Poorly correlated
-6.06%
GRRMF - SAFLF
24%
Poorly correlated
N/A
AMBBY - SAFLF
24%
Poorly correlated
-1.93%
More